2010 Annual Meeting Brochure
Pre-Meeting Workshop
Managing Diabetes in Patients with Psychiatric Illness
Sunday, April 18, 2010-8:00-11:00 AM
The prevalence of diabetes mellitus has been on the rise in the United States. A survey of inpatient databases suggests that this trend is augmented among psychiatric patients, with a prevalence of 6.9% in 1997 and 14.5% in 2004. Many acutely ill psychiatric patients experiencing anhedonia ignore activities of daily living and healthy lifestyles. Poor diet and exercise regimens in addition to non-adherence increase the risk for medical co-morbidities in this population. Furthermore, several second-generation antipsychotics associated with increased risk of diabetes were introduced over the period overlapping these surveys—clozapine in 1989, risperidone in 1993, olanzapine in 1996, quetiapine in 1997, ziprasidone in 2001, and aripiprazole in 2002.
In their 2008 Guidelines, the American Diabetes Association has published clear recommendations for optimal management of diabetes. These standards provide clinicians and patients with better management strategies to reduce the risk of morbidities and mortality associated with diabetes. The recommendations include screening, diagnostic, and therapeutic interventions. Clinicians caring for the psychiatric population should be familiar with these standards and interventions in order to optimally manage patients, and prevent complications of diabetes during patient lifespans.
Delivered by Dr. Stuart Haines, FCCP, FASHP, FAPhA, Professor and Pharmacotherapy Specialist at the University of Maryland, along with Joshana Goga, PharmD, BCPP, this 3-hour program (worth 3.0 contact hours of ACPE and CME credit) will review the American Diabetes Association standards of care in managing diabetes and invoke case-based discussions on best practices to manage the psychiatric patient with poor glucose control. The discussions will highlight first line agents, adverse effects and monitoring techniques to maintain safe and adequate care.